This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
E32.0
Hospital discharge: ICD-9
2540
Cause of death: ICD-10
E32.0
Cause of death: ICD-9
2540
2 out of 7 registries used, show all original rules.
24
Check minimum number of events None
24
Include endpoints None
24
Remove individuals based on genotype QC
24
E4_HYPERTHY
Control definitions
Control exclude
E4_ENDOGLAND
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E32
Name in latin
Hyperplasia thymi persistens
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Persistent hyperplasia of thymus
based on the number of shared cases.
Broader endpoints:
- Diseases of thymus
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 24 | 11 | 13 |
| Unadjusted prevalence (%) | 0.01 | 0.00 | 0.01 |
| Mean age at first event (years) | 49.83 | 55.20 | 45.29 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_HYPERTHY – Persistent hyperplasia of thymus
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Persistent hyperplasia of thymus
↥Endpoint not on priority list, no data to show.